| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
5 |
/ |
2022 |
|
|
|
| |
Data sporządzenia: |
2022-07-06 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Issuance of Technology-Specific CPT Code for the Company's CompuFlo Epidural System
by American Medical Association
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that the American Medical Association _AMA_ has issued a new technology-specific
Category III Current Procedural Terminology _CPT_ code for the Company's CompuFlo
Epidural system. The AMA CPT Editorial Panel accepted the Company's request to add
a Category III code to report use of a real-time pressure sensing guidance system.
The new CPT code goes into effect in the CPT codebook on January 1, 2023.
The specific code was granted after review and validation of the technology by the
CPT Editorial Panel at its May 2022 meeting. The CPT codes created and maintained
by the AMA CPT Editorial Panel are widely used by government payers, including Medicare
and Medicaid, and commercial health plans. The approved Category III CPT code will
be in effect for at least five years, at which time the AMA may award a Category I
code.
The Board of Directors of the Company believes that receiving a technology-specific
CPT code for CompuFlo marks an important milestone, that could increase the potential
number of anesthesia pain management clinics adopting the CompuFlo, as the receipt
of CPT code expands potential for reimbursement of epidural procedures in pain management
utilizing the CompuFlo Epidural System.
Aside from the clinical benefits, this code is expected to play an important role
in private pain clinics and hospital settings, where administration financial decision
making could be made easier thereby helping accelerate the commercial roll-out of
CompuFlo in the U.S. Furthermore, it will potentially assist in enhancing market penetration
within the chronic pain segment, which is estimated to be at least twice the size
of the labor and delivery market segment.
The Company is actively preparing a full launch plan in anticipation of this new AMA-cleared
CPT code that will be implemented in the first quarter of 2023.
|
|
|
RB_ASO: Issuance of Technology-Specific CPT Code for the Company's CompuFlo Epidural System
by American Medical Association
